1. maxgoh476
2. bwasmw
3. jakki61
1.bwasmw 10/08/2018
Altimmune Announces $25 million Registered Direct Offering
2.jakki61 03/28/2018
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B
3.bwasmw 03/12/2018
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW